BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 8649852)

  • 81. Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis.
    Oliverio S; Amendola A; Di Sano F; Farrace MG; Fesus L; Nemes Z; Piredda L; Spinedi A; Piacentini M
    Mol Cell Biol; 1997 Oct; 17(10):6040-8. PubMed ID: 9315663
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Regulation of the retinoblastoma-dependent Mdm2 and E2F-1 signaling pathways during neuronal apoptosis.
    Trinh E; Boutillier AL; Loeffler JP
    Mol Cell Neurosci; 2001 Feb; 17(2):342-53. PubMed ID: 11178871
    [TBL] [Abstract][Full Text] [Related]  

  • 83. RB and hbrm cooperate to repress the activation functions of E2F1.
    Trouche D; Le Chalony C; Muchardt C; Yaniv M; Kouzarides T
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11268-73. PubMed ID: 9326598
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis.
    Almasan A; Yin Y; Kelly RE; Lee EY; Bradley A; Li W; Bertino JR; Wahl GM
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5436-40. PubMed ID: 7777526
    [TBL] [Abstract][Full Text] [Related]  

  • 85. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB.
    Haupt Y; Rowan S; Oren M
    Oncogene; 1995 Apr; 10(8):1563-71. PubMed ID: 7731711
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation.
    Bergh G; Ehinger M; Olofsson T; Baldetorp B; Johnsson E; Brycke H; Lindgren G; Olsson I; Gullberg U
    Blood; 1997 Apr; 89(8):2938-50. PubMed ID: 9108414
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression.
    Hiebert SW
    Mol Cell Biol; 1993 Jun; 13(6):3384-91. PubMed ID: 8497257
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Alterations in G1/S cell-cycle control contributing to carcinogenesis.
    Kaelin WG
    Ann N Y Acad Sci; 1997 Dec; 833():29-33. PubMed ID: 9616737
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques.
    Bennett MR; Macdonald K; Chan SW; Boyle JJ; Weissberg PL
    Circ Res; 1998 Apr; 82(6):704-12. PubMed ID: 9546379
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.
    Agah R; Kirshenbaum LA; Abdellatif M; Truong LD; Chakraborty S; Michael LH; Schneider MD
    J Clin Invest; 1997 Dec; 100(11):2722-8. PubMed ID: 9389735
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
    Qin XQ; Livingston DM; Kaelin WG; Adams PD
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10918-22. PubMed ID: 7971984
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effects of insulin on TGF-beta 1-induced cell growth inhibition in the human hepatoma cell lines.
    Hung WC; Chuang LY; Tsai JH; Chang CC
    Biochem Mol Biol Int; 1993 Jul; 30(4):655-63. PubMed ID: 8401323
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein.
    Iavarone A; Garg P; Lasorella A; Hsu J; Israel MA
    Genes Dev; 1994 Jun; 8(11):1270-84. PubMed ID: 7926730
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-β-induced apoptosis of liver tumor cells.
    Sancho P; Fabregat I
    Biochem Pharmacol; 2011 Apr; 81(7):917-24. PubMed ID: 21276422
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis.
    Shan B; Durfee T; Lee WH
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):679-84. PubMed ID: 8570615
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway.
    Hofmann F; Martelli F; Livingston DM; Wang Z
    Genes Dev; 1996 Dec; 10(23):2949-59. PubMed ID: 8956996
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A study of biological function of retinoblastoma gene (Rb gene).
    Chen D; Li D; Huang Q; Li A; Gu J; Luo C
    Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):87-97. PubMed ID: 7656727
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Inhibition of hepatocyte DNA synthesis by transforming growth factor beta 1 and cyclic AMP: effect immediately before the G1/S border.
    Thoresen GH; Refsnes M; Christoffersen T
    Cancer Res; 1992 Jul; 52(13):3598-603. PubMed ID: 1319826
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation.
    Yen A; Varvayanis S
    Exp Cell Res; 1994 Sep; 214(1):250-7. PubMed ID: 8082728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.